Publications

1. Yamaguchi M, Hankinson O. An aryl hydrocarbon receptor agonist suppresses the growth of human umbilical vein endothelial cells in vitro: Potent effect with polyunsaturated fatty acids.. International journal of experimental pathology, 2020.
2. Huerta-Yepez S, Tirado-Rodriguez A, Montecillo-Aguado MR, Yang J, Hammock BD, Hankinson O. Aryl Hydrocarbon Receptor-Dependent inductions of omega-3 and omega-6 polyunsaturated fatty acid metabolism act inversely on tumor progression.. Scientific reports, 2020.
3. Sundberg CD, Hankinson O. A CRISPR/Cas9 Whole-Genome Screen Identifies Genes Required for Aryl Hydrocarbon Receptor-Dependent Induction of Functional CYP1A1.. Toxicological sciences : an official journal of the Society of Toxicology, 2019.
4. Yamaguchi M, Hankinson O. 2,3,7,8‑tetrachlorodibenzo‑p‑dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.. International journal of oncology, 2019.
5. Yamaguchi M, Osuka S, Hankinson O, Murata T. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro.. International journal of oncology, 2018.
6. Yamaguchi M, Hankinson O. 2,3,7,8‑Tetrachlorodibenzo‑p‑dioxin suppresses the growth of human liver cancer HepG2 cells in vitro: Involvement of cell signaling factors.. International journal of oncology, 2018.
7. Beischlag TV, Prefontaine GG, Hankinson O. ChIP-re-ChIP: Co-occupancy Analysis by Sequential Chromatin Immunoprecipitation.. Methods in molecular biology (Clifton, N.J.), 2018.
8. Huerta-Yépez S, Tirado-Rodriguez AB, Hankinson O. Role of diets rich in omega-3 and omega-6 in the development of cancer.. Boletin medico del Hospital Infantil de Mexico, 2016.
9. Hankinson O. The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids.. Drug metabolism reviews, 2016.
10. Solaimani P, Wang F, Hankinson O. SIN3A, generally regarded as a transcriptional repressor, is required for induction of gene transcription by the aryl hydrocarbon receptor.. The Journal of biological chemistry, 2014.
11. Solaimani P, Damoiseaux R, Hankinson O. Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.. Toxicological sciences : an official journal of the Society of Toxicology, 2013.
12. Ingelman-Sundberg M, Zhong XB, Hankinson O, Beedanagari S, Yu AM, Peng L, Osawa Y. Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport.. Drug metabolism and disposition: the biological fate of chemicals, 2013.
13. Yang J, Solaimani P, Dong H, Hammock B, Hankinson O. Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung.. The Journal of toxicological sciences, 2013.
14. Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, Antonio-Andres G, Bonavida B, Riedl M, Kleerup E, Tashkin DP, Hankinson O, Huerta-Yepez S. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation.. Respiratory research, 2012.
15. Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW. The transcription factor encyclopedia.. Genome biology, 2012.
16. Bui P, Solaimani P, Wu X, Hankinson O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion.. Toxicology and applied pharmacology, 2011.
17. Bebenek IG, Solaimani P, Bui P, Hankinson O. CYP2S1 is negatively regulated by corticosteroids in human cell lines.. Toxicology letters, 2011.
18. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, Riedl M, Diaz-Sanchez D, Kleerup E, Tashkin DP, Gonzalez FJ, Bonavida B, Zeidler M, Hankinson O. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis.. Allergy, 2011.
19. Quesada A, Bui PH, Homanics GE, Hankinson O, Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor.. European journal of pharmacology, 2011.
20. Bui P, Imaizumi S, Beedanagari SR, Reddy ST, Hankinson O. Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids.. Drug metabolism and disposition: the biological fate of chemicals, 2010.
21. Beedanagari SR, Taylor RT, Bui P, Wang F, Nickerson DW, Hankinson O. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes.. Molecular pharmacology, 2010.
22. Wang F, Zhang R, Wu X, Hankinson O. Roles of coactivators in hypoxic induction of the erythropoietin gene.. PloS one, 2010.
23. Shi S, Yoon DY, Hodge-Bell K, Huerta-Yepez S, Hankinson O. Aryl hydrocarbon nuclear translocator (hypoxia inducible factor 1beta) activity is required more during early than late tumor growth.. Molecular carcinogenesis, 2010.
24. Beedanagari SR, Taylor RT, Hankinson O. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines.. Toxicology letters, 2010.
25. Shi S, Yoon DY, Hodge-Bell KC, Bebenek IG, Whitekus MJ, Zhang R, Cochran AJ, Huerta-Yepez S, Yim SH, Gonzalez FJ, Jaiswal AK, Hankinson O. The aryl hydrocarbon receptor nuclear translocator (Arnt) is required for tumor initiation by benzo[a]pyrene.. Carcinogenesis, 2009.
26. Bui PH, Hsu EL, Hankinson O. Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol.. Molecular pharmacology, 2009.
27. Bui PH, Hankinson O. Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli.. Molecular pharmacology, 2009.
28. Hankinson O. Repression of aryl hydrocarbon receptor transcriptional activity by epidermal growth factor.. Molecular interventions, 2009.
29. Beedanagari SR, Bebenek I, Bui P, Hankinson O. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.. Toxicological sciences : an official journal of the Society of Toxicology, 2009.
30. Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O. Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals.. Journal of oncology, 2009.
31. Büchler P, Reber HA, Tomlinson JS, Hankinson O, Kallifatidis G, Friess H, Herr I, Hines OJ. Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.. Neoplasia (New York, N.Y.), 2009.
32. Taylor RT, Wang F, Hsu EL, Hankinson O. Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells.. Toxicological sciences : an official journal of the Society of Toxicology, 2008.
33. Hankinson O. Why does ARNT2 behave differently from ARNT?. Toxicological sciences : an official journal of the Society of Toxicology, 2008.
34. Bui PH, Quesada A, Handforth A, Hankinson O. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil.. Drug metabolism and disposition: the biological fate of chemicals, 2008.
35. Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O. CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3'-diindolylmethane for breast and ovarian cancers.. Cancer letters, 2008.
36. Wang F, Zhang R, Shi S, Hankinson O. The effect of aromatic hydrocarbon receptor on the phenotype of the Hepa 1c1c7 murine hepatoma cells in the absence of dioxin.. Gene regulation and systems biology, 2007.
37. Wang F, Zhang R, Xia T, Hsu E, Cai Y, Gu Z, Hankinson O. Inhibitory effects of nitric oxide on invasion of human cancer cells.. Cancer letters, 2007.
38. Hsu EL, Yoon D, Choi HH, Wang F, Taylor RT, Chen N, Zhang R, Hankinson O. A proposed mechanism for the protective effect of dioxin against breast cancer.. Toxicological sciences : an official journal of the Society of Toxicology, 2007.
39. Rivera SP, Saarikoski ST, Sun W, Hankinson O. Identification of novel dioxin-responsive genes by representational difference analysis.. Xenobiotica; the fate of foreign compounds in biological systems, 2007.
40. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, Hankinson O. A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia.. The Journal of biological chemistry, 2007.
41. Wang F, Shi S, Zhang R, Hankinson O. Identifying target genes of the aryl hydrocarbon receptor nuclear translocator (Arnt) using DNA microarray analysis.. Biological chemistry, 2006.
42. Saarikoski ST, Rivera SP, Hankinson O, Husgafvel-Pursiainen K. CYP2S1: a short review.. Toxicology and applied pharmacology, 2005.
43. Rivera SP, Choi HH, Chapman B, Whitekus MJ, Terao M, Garattini E, Hankinson O. Identification of aldehyde oxidase 1 and aldehyde oxidase homologue 1 as dioxin-inducible genes.. Toxicology, 2005.
44. Hankinson O. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor.. Archives of biochemistry and biophysics, 2005.
45. Fretland AJ, Safe S, Hankinson O. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.. Chemico-biological interactions, 2004.
46. Beischlag TV, Taylor RT, Rose DW, Yoon D, Chen Y, Lee WH, Rosenfeld MG, Hankinson O. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia.. The Journal of biological chemistry, 2004.
47. Wang F, Zhang R, Beischlag TV, Muchardt C, Yaniv M, Hankinson O. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene.. The Journal of biological chemistry, 2004.
48. Wang S, Ge K, Roeder RG, Hankinson O. Role of mediator in transcriptional activation by the aryl hydrocarbon receptor.. The Journal of biological chemistry, 2004.
49. Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, Rajasekaran AK. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.. Cancer research, 2003.
50. Saarikoski ST, Rivera SP, Hankinson O. Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia.. FEBS letters, 2002.
51. Beischlag TV, Wang S, Rose DW, Torchia J, Reisz-Porszasz S, Muhammad K, Nelson WE, Probst MR, Rosenfeld MG, Hankinson O. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.. Molecular and cellular biology, 2002.
52. Rivera SP, Saarikoski ST, Hankinson O. Identification of a novel dioxin-inducible cytochrome P450.. Molecular pharmacology, 2002.
53. Wang S, Hankinson O. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex.. The Journal of biological chemistry, 2002.
54. Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA, Hankinson O. Identification of genes differentially induced by hypoxia in pancreatic cancer cells.. Biochemical and biophysical research communications, 2001.
55. Anttila S, Tuominen P, Hirvonen A, Nurminen M, Karjalainen A, Hankinson O, Elovaara E. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor.. Pharmacogenetics, 2001.
56. Lei XD, Chapman B, Hankinson O. Loss of cyp1a1 messenger rna expression due to nonsense-mediated decay.. Molecular pharmacology, 2001.
57. Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol.. American journal of respiratory cell and molecular biology, 2001.
58. Heo Y, Saxon A, Hankinson O. Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice.. Toxicology, 2001.
59. Anttila S, Lei XD, Elovaara E, Karjalainen A, Sun W, Vainio H, Hankinson O. An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes.. Pharmacogenetics, 2000.
60. Sun W, Zhang J, Hankinson O. A mutation in the aryl hydrocarbon receptor (AHR) in a cultured mammalian cell line identifies a novel region of AHR that affects DNA binding.. The Journal of biological chemistry, 1997.
61. Kozak KR, Abbott B, Hankinson O. ARNT-deficient mice and placental differentiation.. Developmental biology, 1997.
62. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.. Proceedings of the National Academy of Sciences of the United States of America, 1997.
63. Probst MR, Fan CM, Tessier-Lavigne M, Hankinson O. Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator protein.. The Journal of biological chemistry, 1997.
64. Sindhu RK, Reisz-Porszasz S, Hankinson O, Kikkawa Y. Induction of cytochrome P4501A1 by photooxidized tryptophan in Hepa lclc7 cells.. Biochemical pharmacology, 1996.
65. Zhang J, Watson AJ, Probst MR, Minehart E, Hankinson O. Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line.. Molecular pharmacology, 1996.
66. Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratcliffe PJ. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.. The Journal of biological chemistry, 1996.
67. Bacsi SG, Hankinson O. Functional characterization of DNA-binding domains of the subunits of the heterodimeric aryl hydrocarbon receptor complex imputing novel and canonical basic helix-loop-helix protein-DNA interactions.. The Journal of biological chemistry, 1996.
68. Fukunaga BN, Hankinson O. Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding.. The Journal of biological chemistry, 1996.
69. Fukunaga BN, Probst MR, Reisz-Porszasz S, Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor.. The Journal of biological chemistry, 1995.
70. Bacsi SG, Reisz-Porszasz S, Hankinson O. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.. Molecular pharmacology, 1995.
71. Reisz-Porszasz S, Probst MR, Fukunaga BN, Hankinson O. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT).. Molecular and cellular biology, 1994.
72. Hankinson O. The role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon receptor action.. Trends in endocrinology and metabolism: TEM, 1994.
73. Hankinson O. A genetic analysis of processes regulating cytochrome P4501A1 expression.. Advances in enzyme regulation, 1994.
74. Probst MR, Reisz-Porszasz S, Agbunag RV, Ong MS, Hankinson O. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.. Molecular pharmacology, 1993.
75. Reisz-Porszasz S, Reyes H, DeLuca HF, Prahl JM, Hankinson O. Investigation on the potential role of the Ah receptor nuclear translocator protein in vitamin D receptor action.. Journal of receptor research, 1993.
76. Hankinson O. Research on the aryl hydrocarbon (dioxin) receptor is primed to take off.. Archives of biochemistry and biophysics, 1993.
77. Johnson BS, Brooks BA, Reyes H, Hoffman EC, Hankinson O. An MspI RFLP in the human ARNT gene, encoding a subunit of the nuclear form of the Ah (dioxin) receptor.. Human molecular genetics, 1992.
78. Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor.. Science (New York, N.Y.), 1992.
79. Watson AJ, Weir-Brown KI, Bannister RM, Chu FF, Reisz-Porszasz S, Fujii-Kuriyama Y, Sogawa K, Hankinson O. Mechanism of action of a repressor of dioxin-dependent induction of Cyp1a1 gene transcription.. Molecular and cellular biology, 1992.
80. Watson AJ, Hankinson O. Dioxin- and Ah receptor-dependent protein binding to xenobiotic responsive elements and G-rich DNA studied by in vivo footprinting.. The Journal of biological chemistry, 1992.
81. Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor.. Science (New York, N.Y.), 1991.
82. Hankinson O, Brooks BA, Weir-Brown KI, Hoffman EC, Johnson BS, Nanthur J, Reyes H, Watson AJ. Genetic and molecular analysis of the Ah receptor and of Cyp1a1 gene expression.. Biochimie, 1991.
83. Hankinson O. Selections for and against cells possessing cytochrome P450IA1-dependent aryl hydrocarbon hydroxylase activity.. Methods in enzymology, 1991.
84. Watson AJ, Hankinson O. DNA transfection of a gene repressing aryl hydrocarbon hydroxylase induction.. Carcinogenesis, 1988.
85. Karenlampi SO, Legraverend C, Gudas JM, Carramanzana N, Hankinson O. A third genetic locus affecting the Ah (dioxin) receptor.. The Journal of biological chemistry, 1988.
86. Gudas JM, Hankinson O. Regulation of cytochrome P-450c in differentiated and dedifferentiated rat hepatoma cells: role of the Ah receptor.. Somatic cell and molecular genetics, 1987.
87. Kimura S, Smith HH, Hankinson O, Nebert DW. Analysis of two benzo[a]pyrene-resistant mutants of the mouse hepatoma Hepa-1 P(1)450 gene via cDNA expression in yeast.. The EMBO journal, 1987.
88. Gudas JM, Karenlampi SO, Hankinson O. Intracellular location of the Ah receptor.. Journal of cellular physiology, 1986.
89. Gudas JM, Hankinson O. Reversible inactivation of the Ah receptor associated with changes in intracellular ATP levels.. Journal of cellular physiology, 1986.
90. Kärenlampi SO, Montisano DF, Gudas JM, Hankinson O. DNA-mediated restoration of aryl hydrocarbon hydroxylase induction in a mouse hepatoma mutant defective in nuclear translocation of the Ah receptor.. Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1986.
91. Montisano DF, Hankinson O. Transfection by genomic DNA of cytochrome P1-450 enzymatic activity and inducibility.. Molecular and cellular biology, 1985.
92. Hankinson O, Andersen RD, Birren BW, Sander F, Negishi M, Nebert DW. Mutations affecting the regulation of transcription of the cytochrome P1-450 gene in the mouse Hepa-1 cell line.. The Journal of biological chemistry, 1985.
93. Van Gurp JR, Hankinson O. Isolation and characterization of revertants from four different classes of aryl hydrocarbon hydroxylase-deficient hepa-1 mutants.. Molecular and cellular biology, 1984.
94. Nebert DW, Eisen HJ, Hankinson O. The Ah receptor: binding specificity only for foreign chemicals?. Biochemical pharmacology, 1984.
95. Van Gurp JR, Hankinson O. Single-step phototoxic selection procedure for isolating cells that possess aryl hydrocarbon hydroxylase.. Cancer research, 1983.
96. Duthu GS, Hankinson O. The defects in all classes of aryl hydrocarbon hydroxylase-deficient mutant of mouse hepatoma line, Hepa-1, are restricted to activities catalyzed by cytochrome P-450.. Cancer letters, 1983.
97. Kärenlampi SO, Eisen HJ, Hankinson O, Nebert DW. Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells.. The Journal of biological chemistry, 1983.
98. Hankinson O. Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to three complementation groups.. Somatic cell genetics, 1983.
99. Duthu GS, Nestor MS, Berliner JA, Philpot RM, Hankinson O. Characterization of NADPH-cytochrome P-450 reductase in a mouse hepatoma cell line.. Cancer letters, 1983.
100. Legraverend C, Hannah RR, Eisen HJ, Owens IS, Nebert DW, Hankinson O. Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones.. The Journal of biological chemistry, 1982.
101. Hankinson O. Evidence that Benzo(a) pyrene-resistant, aryl hydrocarbon hydroxylase-deficient variants of mouse hepatoma line, Hepa-1, are mutational in origin.. Somatic cell genetics, 1981.
102. Hankinson O. Unstable aryl hydrocarbon hydroxylase-deficient variants of a rat hepatoma line.. Somatic cell genetics, 1980.
103. Hankinson O. Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase.. Proceedings of the National Academy of Sciences of the United States of America, 1979.